Mature Survival Data from RTOG 9802: A Phase III Study of Radiation Therapy (RT) With or Without Procarbazine, CCNU, and Vincristine (PCV) for Adult Patients with High-Risk Low-Grade Glioma (LGG) Conference

Mehta, MP, Won, M, Shaw, EG et al. (2014). Mature Survival Data from RTOG 9802: A Phase III Study of Radiation Therapy (RT) With or Without Procarbazine, CCNU, and Vincristine (PCV) for Adult Patients with High-Risk Low-Grade Glioma (LGG) . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 90 S37-S38. 10.1016/j.ijrobp.2014.05.153

Open Access International Collaboration

cited authors

  • Mehta, MP; Won, M; Shaw, EG; Buckner, J; Gilbert, M; Barger, G; Coons, S; Ricci, P; Bullard, D; Brown, PD; Stelzer, K; Brachman, DG; Suh, JH; Schultz, C; Bahary, J; Fisher, BJ; Kim, H; Murtha, AD; Curran, WJ

sustainable development goals

authors

date/time interval

  • September 14, 2014 -

publication date

  • September 1, 2014

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology

Location

  • San Francisco, CA

Digital Object Identifier (DOI)

Conference

  • 56th Annual Meeting of the American-Society-for-Radiation-Oncology

publisher

  • ELSEVIER SCIENCE INC

start page

  • S37

end page

  • S38

volume

  • 90